JP2005519878A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519878A5
JP2005519878A5 JP2003546881A JP2003546881A JP2005519878A5 JP 2005519878 A5 JP2005519878 A5 JP 2005519878A5 JP 2003546881 A JP2003546881 A JP 2003546881A JP 2003546881 A JP2003546881 A JP 2003546881A JP 2005519878 A5 JP2005519878 A5 JP 2005519878A5
Authority
JP
Japan
Prior art keywords
pyrazol
hydrazono
ylamine
pyrazole
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2003546881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519878A (ja
Filing date
Publication date
Priority claimed from US10/077,238 external-priority patent/US7105503B2/en
Application filed filed Critical
Priority claimed from PCT/CA2002/001583 external-priority patent/WO2003045379A1/en
Publication of JP2005519878A publication Critical patent/JP2005519878A/ja
Publication of JP2005519878A5 publication Critical patent/JP2005519878A5/ja
Ceased legal-status Critical Current

Links

JP2003546881A 2001-11-30 2002-10-18 ヒドラゾノピラゾール誘導体および治療剤としてのその使用 Ceased JP2005519878A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33526501P 2001-11-30 2001-11-30
US10/077,238 US7105503B2 (en) 2000-04-07 2002-02-15 Pyrazole compounds
PCT/CA2002/001583 WO2003045379A1 (en) 2001-11-30 2002-10-18 Hydrazonopyrazole derivatives and their use as therapeutics

Publications (2)

Publication Number Publication Date
JP2005519878A JP2005519878A (ja) 2005-07-07
JP2005519878A5 true JP2005519878A5 (https=) 2010-09-30

Family

ID=26759053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003546881A Ceased JP2005519878A (ja) 2001-11-30 2002-10-18 ヒドラゾノピラゾール誘導体および治療剤としてのその使用

Country Status (9)

Country Link
US (3) US7875728B2 (https=)
EP (1) EP1450791A1 (https=)
JP (1) JP2005519878A (https=)
CN (1) CN1671379A (https=)
AU (2) AU2002333114B2 (https=)
CA (1) CA2468562C (https=)
MX (1) MXPA04005204A (https=)
RU (1) RU2332996C2 (https=)
WO (1) WO2003045379A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY2010012I2 (el) 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
RU2332996C2 (ru) 2001-11-30 2008-09-10 КьюЭлТи Инк. Производные гидразонпиразола и их применение в качестве лекарственного средства
TWI280128B (en) 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
TW200526638A (en) 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
GB0419416D0 (en) * 2004-09-01 2004-10-06 Inst Of Ex Botany Ascr 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
GB0908614D0 (en) 2009-05-19 2009-06-24 Tayside Flow Technologies Ltd A vascular graft
MX2011012668A (es) 2009-05-29 2011-12-16 Glaxosmithkline Llc Metodos de administracion de compuestos agonistas de trombopoyetina.
RU2546005C2 (ru) 2009-09-15 2015-04-10 Кью Эл Ти ИНК. Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе
US9173856B2 (en) 2010-04-19 2015-11-03 Qlt Inc. Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
CA2865935C (en) 2012-03-01 2021-12-14 Qlt Inc. Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency
CN104958288B (zh) * 2015-06-26 2017-08-11 苏州大学 一种血小板抑制剂及其在制备抗血小板疾病药物中的应用
KR102128509B1 (ko) * 2018-12-19 2020-07-01 한국과학기술연구원 말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도
KR102356644B1 (ko) * 2020-06-19 2022-01-28 한국과학기술연구원 신규한 옥소피리다지닐-페닐-카르보노하이드라조노일 디시아나이드 화합물 및 이의 용도
EP4169916A4 (en) * 2020-06-19 2024-07-10 Korea Institute of Science and Technology CARBONOHYDRAZONOYL DICYANIDE COMPOUND COMPRISING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY A NOVEL LINKER, AND USE THEREOF
KR102633087B1 (ko) * 2020-06-19 2024-02-05 한국과학기술연구원 신규한 융합헤테로고리-카르보노하이드라조노일 디시아나이드 화합물 및 이의 용도
CN113583110B (zh) * 2021-08-19 2023-07-21 华南农业大学 一种苯并三唑半抗原、人工抗原和抗体及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH373842A (de) * 1959-09-11 1963-12-15 Geigy Ag J R Verfahren zur Herstellung von in Wasser dispergierbaren, schwer löslichen Azofarbstoffen
NL127251C (https=) * 1965-01-15
DE2248738A1 (de) * 1972-10-05 1974-04-11 Bayer Ag Kationische diazacyaninfarbstoffe
SU1162799A1 (ru) * 1982-07-09 1985-06-23 Витебский государственный медицинский институт Способ получени 4-арилгидразонов пиразолидинтриона-3,4,5
US4562248A (en) * 1983-11-25 1985-12-31 Eastman Kodak Company Azo dyes from unsubstituted or substituted 3-amino-pyridine and aryl or heterocyclic couplers
CA2369076A1 (en) 2000-02-05 2001-08-09 Vertex Pharmaceuticals Incorporated Pyrazole compositions useful as inhibitors of erk
HUP0202332A2 (en) 2000-02-05 2002-10-28 Vertex Pharma Pyrazole compositions useful as inhibitors of erk
WO2001056557A2 (en) 2000-02-05 2001-08-09 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of erk
US6436915B1 (en) * 2000-04-07 2002-08-20 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US6214813B1 (en) * 2000-04-07 2001-04-10 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
RU2332996C2 (ru) 2001-11-30 2008-09-10 КьюЭлТи Инк. Производные гидразонпиразола и их применение в качестве лекарственного средства
EP1456180B1 (en) 2001-12-21 2007-10-03 Vernalis (Cambridge) Limited 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use

Similar Documents

Publication Publication Date Title
JP2005519878A5 (https=)
RU2332996C2 (ru) Производные гидразонпиразола и их применение в качестве лекарственного средства
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
AU734275C (en) Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
ES2536191T3 (es) Derivados de sulfonamida
RU2426731C2 (ru) Производные арил-изоксазоло-4-ил-оксадиазола
JP2006505512A5 (https=)
JP2006503081A5 (https=)
ZA200305619B (en) Substituted triazole diamine derivatives as kinase inhibitors.
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
TWI659950B (zh) 作為硝醯基予體之吡唑啉酮衍生物
CA2466490A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
RU2006127575A (ru) Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
KR19990063874A (ko) 항염증제로서 수의학적 치료에 사용하기 위한 치환 피라졸릴 벤젠술폰아미드
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
WO2004045509A2 (en) Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy
RU96100763A (ru) Фенильные гетероциклы как ингибиторы циклооксигеназы-2
CA2440238A1 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
JP2007516173A5 (https=)
JP2008044952A (ja) 高コンダクタンス型カルシウム感受性kチャネル開口薬
RU96115039A (ru) Пиразолилзамещенные бензолсульфонамиды для лечения воспалений
EP2906553A1 (en) Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero)aryl)-pyrrolidin-1-yl]-methanone derivatives
US20040138261A1 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
RU2011116232A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы